BRIEF-Ultragenyx Provides Financial And Business Updates At J.P. Morgan Annual Healthcare Conference

Reuters01-12

Jan 12 (Reuters) - Ultragenyx Pharmaceutical Inc RARE.O:

ULTRAGENYX PROVIDES FINANCIAL AND BUSINESS UPDATES AT J.P. MORGAN ANNUAL HEALTHCARE CONFERENCE
2025 REVENUE EXCEEDS GUIDANCE AT $672 MILLION-$674 MILLION
CASH AND INVESTMENTS ABOUT $735 MILLION AS OF DEC 31, 2025
FY2025 REVENUE VIEW $655.6 MILLION -- LSEG IBES DATA

Source text: ID:nGNX3xlWJW

Further company coverage: RARE.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2602517539?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-12 20:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2602517539","market":"nz","top_or_hot":-1,"title":"BRIEF-Ultragenyx Provides Financial And Business Updates At J.P. Morgan Annual Healthcare Conference","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Ultragenyx Provides Financial And Business Updates At J.P. Morgan Annual Healthcare Conference</title></head><body><p><span>Jan 12 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/RARE\">Ultragenyx Pharmaceutical Inc</a> <span>RARE.O</span>:</p><ul><li><p>ULTRAGENYX PROVIDES FINANCIAL AND BUSINESS UPDATES AT J.P. MORGAN ANNUAL HEALTHCARE CONFERENCE</p></li><li><p>2025 REVENUE EXCEEDS GUIDANCE AT $672 MILLION-$674 MILLION</p></li><li><p>CASH AND INVESTMENTS ABOUT $735 MILLION AS OF DEC 31, 2025</p></li><li><p>FY2025 REVENUE VIEW $655.6 MILLION -- LSEG IBES DATA</p></li></ul><p>Source text: <span>ID:nGNX3xlWJW</span></p><p>Further company coverage: <span>RARE.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Ultragenyx Provides Financial And Business Updates At J.P. Morgan Annual Healthcare Conference</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Ultragenyx Provides Financial And Business Updates At J.P. Morgan Annual Healthcare Conference\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-12 20:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Ultragenyx Provides Financial And Business Updates At J.P. Morgan Annual Healthcare Conference</title></head><body><p><span>Jan 12 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/RARE\">Ultragenyx Pharmaceutical Inc</a> <span>RARE.O</span>:</p><ul><li><p>ULTRAGENYX PROVIDES FINANCIAL AND BUSINESS UPDATES AT J.P. MORGAN ANNUAL HEALTHCARE CONFERENCE</p></li><li><p>2025 REVENUE EXCEEDS GUIDANCE AT $672 MILLION-$674 MILLION</p></li><li><p>CASH AND INVESTMENTS ABOUT $735 MILLION AS OF DEC 31, 2025</p></li><li><p>FY2025 REVENUE VIEW $655.6 MILLION -- LSEG IBES DATA</p></li></ul><p>Source text: <span>ID:nGNX3xlWJW</span></p><p>Further company coverage: <span>RARE.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RARE","symbol_name":"Ultragenyx Pharmaceutical Inc","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUABZGY7M:1","article_id":"2602517539","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2602517539","pubTimestamp":1768221762,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Ultragenyx Provides Financial And Business Updates At J.P. Morgan Annual Healthcare ConferenceJan 12 (Reuters) - Ultragenyx Pharmaceutical Inc RARE.O:ULTRAGENYX PROVIDES FINANCIAL AND BUSINESS U","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RARE":"Ultragenyx Pharmaceutical Inc","BK4139":"生物科技"},"translate_title":"简介-Ultragenyx在摩根大通年度医疗保健会议上提供财务和业务更新","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RARE":0.9},"content_text":"BRIEF-Ultragenyx Provides Financial And Business Updates At J.P. Morgan Annual Healthcare ConferenceJan 12 (Reuters) - Ultragenyx Pharmaceutical Inc RARE.O:ULTRAGENYX PROVIDES FINANCIAL AND BUSINESS UPDATES AT J.P. MORGAN ANNUAL HEALTHCARE CONFERENCE2025 REVENUE EXCEEDS GUIDANCE AT $672 MILLION-$674 MILLIONCASH AND INVESTMENTS ABOUT $735 MILLION AS OF DEC 31, 2025FY2025 REVENUE VIEW $655.6 MILLION -- LSEG IBES DATASource text: ID:nGNX3xlWJWFurther company coverage: RARE.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2602517539","isCrawlerRequest":true}